SOLUTIONS
CONVERT LCs INTO PROTEOFORM METERS
Proteometer-L Kit
World's first nanotechnology for at-line molecular structure analysis!
ENHANCED APPROACH TO PROCESS ANALYTICAL TECHNOLOGY
Learn about the technology & components behind Proteometer Kits.
NOVIPLEX™ PLASMA COLLECTION SOLUTIONS
(NOW TELIMMUNE)
Now sold at Telimmune.com
Whole blood to dried plasma in a quantified volume. Developed for remote sample collection.
ABOUT
Novilytic is a molecular recognition company that utilizes nanotechnology to monitor the quality of lifesaving medicines.
--
The phrase “canary in the coal mine” refers to the use of birds to detect odorless but highly poisonous carbon monoxide gas to keep miners safe. Novilytic has applied this same premise to bioreactors in the pharmaceutical industry.
Our nanotechnology acts as “The Canary in the Fermentor” by allowing scientists to monitor batch quality in-process, an achievement previously thought impossible.
This is critical because existing QC methods take four hours to days, but it only takes an hour or so for significant contaminants to develop - This leads to expensive and time-consuming purification efforts.
Our Proteometer, aka “proteoform meter,” performs at-line, real-time batch analysis roughly every 10 minutes and eliminates the need for sample preparation and a mass spectrometer.
TESTIMONIALS
"We use the Proteometer-L Kit for the rapid analysis of mAbs for titer and aggregate content from cell-free filtrate samples. It eliminates sample preparation steps, Protein A purification, and mass spectrometry analysis steps. I would recommend the Proteometer to any pharmaceutical company to quickly and accurately quantitate mAb titer and aggregate content."
Harsha Gunawardena
Principal Scientist, Janssen Pharmaceuticals (Johnson & Johnson's research division)
“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb (therapeutic mAbs) proteoforms during fermentation. The approach improves product safety, reduces COPQ and post-release testing, and paves the way for real-time product release, reducing inventory costs.”
Martin Long, BSc.
Performance Validation, Inc. – President & CEO
(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)
“The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies. The integration of complementary bioprocess analytical data facilitates decision-making through a powerful link between the manufacturing space and the QC laboratory."
Eugene L. Inman, Ph.D.
Pharmaceutical Quality Consultant
Retired Eli Lilly and Company
> 5,000
Bioreactors Globally
$8M
Raw Material Costs
0 PAT In-Line
= Massive Industry Gap
The Proteometer is the Solution